Medtronic said it has received 26,421 complaints and is aware of 2,175 injuries and one death related to the insulin pumps.
The FDA classified it as a Class I recall, the most serious type, meaning use of the devices could cause serious injury or death.
The pumps may have a missing or broken retainer ring, which is supposed to lock the insulin cartridge into place in the pump’s reservoir compartment. A missing or broken ring could cause too little or too much insulin to be delivered.
Receiving the wrong dose could cause hypoglycemia or hyperglycemia, which can cause loss of consciousness, seizure or death.
Read the full news release here.
More articles on supply chain:
Cardinal surgical gown recall cost $96M
Demand for protective medical supplies surges amid coronavirus fears, AHA says
6 hospitals partnering on drone deliveries
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
